We previously identified overexpression of the transcription factor Late SV40 factor (LSF) in ~90% of human HCC patients which could be significantly correlated with the stages of the disease and ‘gain-of-function’ and ‘loss-of-function’ studies established the significance of LSF in promoting hepatocarcinogenesis [5–9]. Here, TFCP2 is linked to hepatocellular carcinoma.